CCL22 and systemic lupus erythematosus: Reports of serum levels of MDC being increased in systemic sclerosis, but not in systemic lupus erythematosus (SLE)—both diseases that include symptoms of RP—could be indicative of differing mechanisms in the pathogenesis of RP, depending on the disease (Fujii et al., 2004).